(Q30384775)

21 June 2017

title

Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation. (English)

1 reference

21 June 2017

0 references

Marc Baguelin

1

0 references

Stefan Flasche

object named as

Stefan Flasche

series ordinal

4

0 references

Mark Jit

series ordinal

3

object named as

Mark Jit

1 reference

21 June 2017

6

W John Edmunds

1 reference

21 June 2017

2

Albert Jan Van Hoek

1 reference

21 June 2017

Peter J White

5

1 reference

21 June 2017

language of work or name

English

0 references

publication date

21 January 2010

1 reference

21 June 2017

1 reference

21 June 2017

volume

28

1 reference

21 June 2017

issue

12

1 reference

21 June 2017

page(s)

2370-2384

1 reference

Social contacts and mixing patterns relevant to the spread of infectious diseases

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.002

Estimating the impact of school closure on social mixing behaviour and the transmission of close contact infections in eight European countries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.002

Time lines of infection and disease in human influenza: a review of volunteer challenge studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.002

England to launch special flu service next week to take pressure off primary care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.002

Assessing the severity of the novel influenza A/H1N1 pandemic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.002

The 23-Valent Pneumococcal Polysaccharide Vaccine. Part II. A Cost-Effectiveness Analysis for Invasive Disease in the Elderly in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.002

Cost-effectiveness of antiviral stockpiling and near-patient testing for potential influenza pandemic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.002

Evaluating rotavirus vaccination in England and Wales. Part I. Estimating the burden of disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.002

The transmissibility and control of pandemic influenza A (H1N1) virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.002

Optimizing influenza vaccine distribution.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.002

Does receipt of seasonal influenza vaccine predict intention to receive novel H1N1 vaccine: evidence from a nationally representative survey of U.S. adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.002

Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.002

Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.002

Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.002

10.1016/J.VACCINE.2010.01.002

7 January 2021

Identifiers

DOI

1 reference

21 June 2017

1 reference